Related references
Note: Only part of the references are listed.MicroRNA-497-5p inhibits proliferation and invasion of non-small cell lung cancer by regulating FGF2
Xiaori Huang et al.
ONCOLOGY LETTERS (2019)
LINC00152/miR-139-5p regulates gastric cancer cell aerobic glycolysis by targeting PRKAA1
Keke Sun et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Potential role of miR-139-5p in cancer diagnosis, prognosis and therapy
Ling-Li Huang et al.
ONCOLOGY LETTERS (2017)
MicroRNA-216a inhibits the metastasis of gastric cancer cells by targeting JAK2/STAT3-mediated EMT process
Youmao Tao et al.
ONCOTARGET (2017)
MicroRNA-93 promotes proliferation and metastasis of gastric cancer via targeting TIMP2
Hao Guan et al.
PLOS ONE (2017)
MiR-139-5p as a novel serum biomarker for recurrence and metastasis in colorectal cancer
Jinsei Miyoshi et al.
SCIENTIFIC REPORTS (2017)
Tumor-suppressive microRNA-34a inhibits breast cancer cell migration and invasion via targeting oncogenic TPD52
Guodong Li et al.
TUMOR BIOLOGY (2016)
Current Perspectives on Gastric Cancer
Juan M. Marques-Lespier et al.
GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2016)
Regulation of TPD52 by antitumor microRNA-218 suppresses cancer cell migration and invasion in lung squamous cell carcinoma
Tomohiro Kumamoto et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
miR-139-5p regulates proliferation, apoptosis, and cell cycle of uterine leiomyoma cells by targeting TPD52 (Publication with Expression of Concern. See vol. 13, pg. 6855, 2020)
Hong Chen et al.
ONCOTARGETS AND THERAPY (2016)
microRNA-218 inhibits prostate cancer cell growth and promotes apoptosis by repressing TPD52 expression
Guangye Han et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Involvement of aberrant miR-139/Jun feedback loop in human gastric cancer
Yan Zhang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2015)
Cancer Statistics, 2015
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
MiR-1271 Inhibits Cell Proliferation, Invasion and EMT in Gastric Cancer by Targeting FOXQ1
Xiao-Jun Xiang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
MicroRNA-139-5p Suppresses 3T3-L1 Preadipocyte Differentiation Through Notch and IRS1/PI3K/Akt Insulin Signaling Pathways
Lin Mi et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2015)
Tumour-suppressive microRNA-224 inhibits cancer cell migration and invasion via targeting oncogenic TPD52 in prostate cancer
Yusuke Goto et al.
FEBS LETTERS (2014)
Patterns of TPD52 overexpression in multiple human solid tumor types analyzed by quantitative PCR
Pierre Tennstedt et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
Tumor protein D52 (TPD52) and cancer-oncogene understudy or understudied oncogene?
Jennifer A. Byrne et al.
TUMOR BIOLOGY (2014)
Molecular diagnosis and therapy for occult peritoneal metastasis in gastric cancer patients
Shunsuke Kagawa et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
MiR-139 Inhibits Mcl-1 Expression and Potentiates TMZ-Induced Apoptosis in Glioma
Rui-Yan Li et al.
CNS NEUROSCIENCE & THERAPEUTICS (2013)
Cancer treatment and survivorship statistics, 2012
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
HER2 Interacts With CD44 to Up-regulate CXCR4 via Epigenetic Silencing of microRNA-139 in Gastric Cancer Cells
Wei Bao et al.
GASTROENTEROLOGY (2011)
MAL2 and tumor protein D52 (TPD52) are frequently overexpressed in ovarian carcinoma, but differentially associated with histological subtype and patient outcome
Jennifer A. Byrne et al.
BMC CANCER (2010)
Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues
Junming Guo et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2009)
Perspectives in Adjuvant Therapy of Gastric Cancer
Ferdinando De Vita et al.
ONCOLOGY (2009)
A Tissue Biomarker Panel Predicting Systemic Progression after PSA Recurrence Post-Definitive Prostate Cancer Therapy
Tohru Nakagawa et al.
PLOS ONE (2008)
A miRNA Signature of Prion Induced Neurodegeneration
Reuben Saba et al.
PLOS ONE (2008)
Share Paper
